Document is current
Any future updates will be listed below
-
Authors
Yang, Jingjing
Peng, Bo
Wang, Lu
Li, Xin
Li, Fei
Jin, Xiangshu
Jia, Mingyu
Xu, Lingmin
Dou, Liping https://orcid.org/0000-0001-7352-9560
Liu, Daihong
-
Funding
Funding for this research was provided by:
Beijing Nova Program (2011114)
National Natural Science Foundation of China (82070178, 81770203, 81700122, 81270610, 30800482)
Beijing Natural Science Foundation of China (7172200, 7132217)
Capital’s Funds for Health Improvement and Research (2016-1-4082)
Fund Sponsorship of the Capital Public Health Project
Hainan Provincial Natural Science Foundation of China (818MS157)
Military Translational Medicine Fund of Chinese PLA General Hospital (ZH19003)
Medical big data and artificial intelligence development fund of Chinese PLA General Hospital (2019MBD-016, 2019MBD-008)
- License Information
-
More Information
Article History
Received: 26 March 2021
Accepted: 16 November 2021
First Online: 23 November 2021
Declarations
:
: This was a single-arm, phase II, open-label, prospective clinical trial (Clinical Trials.gov Identifier: NCT04397367) approved by the Ethics Committee of the Chinese PLA General Hospital. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the guidelines of the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
: Written informed consent was obtained from all individual participants included in the study.
: Not applicable.
: The authors declare no competing interests.
